KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biolife Solutions (BLFS) Non Operating Income (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Non Operating Income for 16 consecutive years, with $3.9 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 5426.03% to $3.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.4 million through Dec 2025, up 260.84% year-over-year, with the annual reading at $4.5 million for FY2025, 204.03% up from the prior year.
  • Non Operating Income for Q4 2025 was $3.9 million at Biolife Solutions, up from $792000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $3.9 million in Q4 2025, with the low at -$5.7 million in Q4 2021.
  • Average Non Operating Income over 5 years is -$86315.8, with a median of $97000.0 recorded in 2024.
  • The sharpest move saw Non Operating Income soared 11871.43% in 2022, then tumbled 1207.55% in 2024.
  • Over 5 years, Non Operating Income stood at -$5.7 million in 2021, then soared by 106.87% to $392000.0 in 2022, then crashed by 78.83% to $83000.0 in 2023, then tumbled by 187.95% to -$73000.0 in 2024, then surged by 5426.03% to $3.9 million in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $3.9 million, $792000.0, and $931000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.